UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New insights in the pathophysiology of ovarian cancer and implications for screening and prevention

American journal of obstetrics and gynecology, 2015-09, Vol.213 (3), p.262-267

2015

Volltextzugriff (PDF)

Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH

Genome research, 2003-02, Vol.13 (2), p.294-307

2003

Volltextzugriff (PDF)

Frequent Amplification of Chromosomal Region 20q12-q13 in Ovarian Cancer

Clinical cancer research, 2000-05, Vol.6 (5), p.1833-1839

2000

Volltextzugriff (PDF)

Multiomic analysis in ovarian clear cell carcinoma to gain insight into biology and therapeutic opportunities

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e17540-e17540

2024

Volltextzugriff (PDF)

Adnexal masses during pregnancy: diagnosis, treatment, and prognosis

American journal of obstetrics and gynecology, 2023-06, Vol.228 (6), p.601-612

2023

Volltextzugriff (PDF)

Brain metastases in ovarian cancer: Association of outcomes with timing of diagnosis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17565-e17565

2022

Volltextzugriff (PDF)

Abstract GMM-037: CARBONIC ANHYDRASE 9 AND TUMOR HYPOXIA ARE ASSOCIATED WITH RECURRENCE AND RESISTANCE IN BRCA1-EXPRESSING HGSOC

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.GMM-037-GMM-037

2019

Volltextzugriff (PDF)

Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial

Clinical cancer research, 2023-08, Vol.29 (15), p.2808-2815

2023

Volltextzugriff (PDF)

Abstract 2577: Pre-cancerous ovarian cells harboring a familial SMARCA4 mutation acquire in vitro phenotypes associated with transformation in SSCOHT

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2577-2577

2023

Volltextzugriff (PDF)

Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020

American journal of obstetrics and gynecology, 2023-10, Vol.229 (4), p.468-470.e5

2023

Volltextzugriff (PDF)

Abstract A064: Study of molecular pathways involved in the development of ovarian cancer brain metastases

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.A064-A064

2024

Volltextzugriff (PDF)

Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma

Cancer epidemiology, biomarkers & prevention, 2023-04, Vol.32 (4), p.542-549

2023

Volltextzugriff (PDF)

Abstract 2645: Targeting mRNA processing pathways in ovarian cancer with a small molecule inhibitor

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2645-2645

2022

Volltextzugriff (PDF)

Clinical data from the DeCidE 1 trial: Assessing the first combination of DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with stage IIc-IV recurrent epithelial ovarian cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5510-5510

2018

Volltextzugriff (PDF)

DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE 1 trial): T cell responses and tumor infiltration correlate with tumor regression

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5576-5576

2019

Volltextzugriff (PDF)

Abstract POSTER-BIOL-1308: Macrophage infiltration in high-grade serous carcinomas of humans and mice

Clinical cancer research, 2015-08, Vol.21 (16_Supplement), p.POSTER-BIOL-1308-POSTER-BIOL-1308

2015

Volltextzugriff (PDF)

Abstract 79: Study of tumor microenvironment of ovarian clear cell carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.79-79

2023

Volltextzugriff (PDF)

Defining Women at High Risk of Ovarian Cancer

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2902-2903

2007

Volltextzugriff (PDF)

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

Cancer epidemiology, biomarkers & prevention, 2017-03, Vol.26 (3), p.420-424

2017

Volltextzugriff (PDF)

Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3072-3072

2015

Volltextzugriff (PDF)

Effect of oral cyclophosphamide on the immunogenicity of DPX-Survivac in ovarian cancer patients: Results of a phase I study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3030-3030

2013

Volltextzugriff (PDF)

Phase I/Ib clinical and immunologic assessment of immunotherapeutic vaccine, DPX-Survivac in women with ovarian, Fallopian tube, or peritoneal cancer (OC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5555-5555

2014

Volltextzugriff (PDF)

Laparoscopic Management of Adnexal Masses

Annals of the New York Academy of Sciences, 2001-09, Vol.943 (1), p.255-268

2001

Volltextzugriff (PDF)

Variation in NF-KB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Cancer epidemiology, biomarkers & prevention, 2014, Vol.23 (7), p.1421-1427

2014

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

New insights in the pathophysiology of ovarian cancer and implications for screening and prevention

Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH

Frequent Amplification of Chromosomal Region 20q12-q13 in Ovarian Cancer

Multiomic analysis in ovarian clear cell carcinoma to gain insight into biology and therapeutic opportunities

Adnexal masses during pregnancy: diagnosis, treatment, and prognosis

Brain metastases in ovarian cancer: Association of outcomes with timing of diagnosis

Abstract GMM-037: CARBONIC ANHYDRASE 9 AND TUMOR HYPOXIA ARE ASSOCIATED WITH RECURRENCE AND RESISTANCE IN BRCA1-EXPRESSING HGSOC

Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial

Abstract 2577: Pre-cancerous ovarian cells harboring a familial SMARCA4 mutation acquire in vitro phenotypes associated with transformation in SSCOHT

Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020

Abstract A064: Study of molecular pathways involved in the development of ovarian cancer brain metastases

Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma

Abstract 2645: Targeting mRNA processing pathways in ovarian cancer with a small molecule inhibitor

Clinical data from the DeCidE 1 trial: Assessing the first combination of DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with stage IIc-IV recurrent epithelial ovarian cancer

DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE 1 trial): T cell responses and tumor infiltration correlate with tumor regression

Abstract POSTER-BIOL-1308: Macrophage infiltration in high-grade serous carcinomas of humans and mice

Abstract 79: Study of tumor microenvironment of ovarian clear cell carcinoma

Defining Women at High Risk of Ovarian Cancer

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer

Effect of oral cyclophosphamide on the immunogenicity of DPX-Survivac in ovarian cancer patients: Results of a phase I study

Phase I/Ib clinical and immunologic assessment of immunotherapeutic vaccine, DPX-Survivac in women with ovarian, Fallopian tube, or peritoneal cancer (OC)

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Laparoscopic Management of Adnexal Masses

Variation in NF-KB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Aktive Filter

Suchergebnisse filtern